683 Capital Management, LLC P Lx Pharma Inc. Transaction History

683 Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.24 - $10.14 $157,200 - $304,200	-30,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.01 - $6.7 $90,300 - $201,000	30,000 New	30,000 $166,000
Q2 2018 Aug 14, 2018	SELL	$3.3 - $4.5 $71,478 - $97,470	-21,660 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.2 - $7.43 $329,270 - $764,524	-102,897 Reduced 82.61%	21,660 $73,000
Q4 2017 Feb 14, 2018	SELL	$6.3 - $9.1 $785,880 - $1.14 Million	-124,743 Reduced 50.04%	124,557 $859,000

Q3 2017 Nov 14, 2017	BUY	$6.08 - $7.0 $1.52 Million - $1.75 Million	249,300	249,300 $1.6 Million

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.